Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker-Reference-Cited by-同舟云学术

Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker

Published:2018-04 Issue:3 Volume:40 Page:200-207
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Abaza Hala M.,Alfeky Mervat A.A.,Eissa Deena S.,Abdel Fattah Mona F.,Annaka Laila M.,Ebeid Fatma S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference32 articles.

1. Acute lymphoblastic leukemia in adolescents and young adults;Ribera;Hematol Oncol Clin North Am,2009

2. Treating childhood acute lymphoblastic leukemia without cranial irradiation;Pui;N Engl J Med,2009

3. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000;Möricke;Leukemia,2010

4. Treatment of adult acute lymphoblastic leukemia;Gökbuget;Semin Hematol,2009

5. Adult acute lymphoblastic leukemia: concepts and strategies;Faderl;Cancer,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-04-30

2. Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches;International Journal of Molecular Sciences;2024-04-24

3. Evaluation of diagnostic efficacy of NRP‐1/CD304 in hematological diseases;Cancer Medicine;2023-03-25

4. High frequency of heat shock protein 27 overexpression is a highly effective, high‐coverage marker for minimal residual disease detection in children with B‐cell acute lymphoblastic leukemia;Pediatric Blood & Cancer;2022-10-17

5. References;Flow Cytometry of Hematological Malignancies;2021-04-06